<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00414297</url>
  </required_header>
  <id_info>
    <org_study_id>61/06</org_study_id>
    <nct_id>NCT00414297</nct_id>
  </id_info>
  <brief_title>External Counterpulsation (ECP) for the Promotion of Collateral Growth in Patients With Coronary Artery Disease</brief_title>
  <official_title>External Counterpulsation (ECP) for the Promotion of Collateral Growth in Patients With Coronary Artery Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital Inselspital, Berne</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital Inselspital, Berne</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study in humans with stable coronary artery disease (CAD) treatable by
      percutaneous coronary intervention (PCI) is to evaluate the efficacy of External
      Counterpulsation (ECP) with regard to the promotion of coronary collateral growth.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Alternative strategies for the promotion of coronary collaterals (arteriogenesis) are a
      promising therapeutic alternative for at least 20% of all Patients with Coronary Artery
      Disease (CAD). Beside growth factors, physical exercise has been shown to improve coronary
      collateral function. Extracorporal Counterpulsation (ECP) mimics physical exercise in a
      standardized way. Before and after ECP treatment, a quantitative invasive assessment of
      absolute collateral flow (by calculating the CFI, i.e. Collateral Flow Index) and myocardial
      perfusion is performed (with calculation of the CPI, i.e. Collateral Perfusion Index and MPR,
      i.e. Myocardial Perfusion Reserve).

      The study setting is single-blinded, sham-controlled and proceptive .
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>August 2006</start_date>
  <completion_date type="Actual">June 2009</completion_date>
  <primary_completion_date type="Actual">December 2008</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Collateral flow index (CFI)</measure>
    <time_frame>21 days</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Coronary collateral resistance (Rcoll)</measure>
    <time_frame>21 days</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Myocardial perfusion reserve</measure>
    <time_frame>21 days</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">30</enrollment>
  <condition>Coronary Artery Disease</condition>
  <arm_group>
    <arm_group_label>1 ECP</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>active ECP Therapy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Sham ECP Treatment</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>ECP Therapy</intervention_name>
    <description>application of ECP Therapy to CAD Patients</description>
    <arm_group_label>1 ECP</arm_group_label>
    <arm_group_label>2</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age &gt; 18 years old

          -  1- to 3-vessel coronary artery disease (CAD)

          -  Stable angina pectoris

          -  At least 1 stenotic lesion suitable for PCI within the next 4 weeks

          -  No Q-wave myocardial infarction in the area undergoing CFI measurement

          -  Written informed consent to participate in the study

        Exclusion Criteria:

          -  Patients admitted as emergencies

          -  Acute myocardial infarction within the last 3 months

          -  Unstable CAD

          -  CAD treated best by CABG

          -  Coronary stenotic lesion to be treated ad-hoc or within &lt; 4 weeks

          -  Severe valve disease

          -  Pulmonary artery hypertension

          -  Congestive heart failure

          -  Atrial fibrillation

          -  Thrombophlebitis and/or deep vein thrombosis

          -  Occlusive peripheral artery disease

          -  Abdominal aortic aneurysm
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Christian Seiler, MD, Prof.</last_name>
    <role>Study Chair</role>
    <affiliation>University of Bern</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Steffen Gloekler, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Bern</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Bern University Hospital</name>
      <address>
        <city>Bern</city>
        <zip>3010</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>October 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 20, 2006</study_first_submitted>
  <study_first_submitted_qc>December 20, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 21, 2006</study_first_posted>
  <last_update_submitted>October 25, 2010</last_update_submitted>
  <last_update_submitted_qc>October 25, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 26, 2010</last_update_posted>
  <responsible_party>
    <name_title>BernUniversity Hospital</name_title>
    <organization>Cardiology</organization>
  </responsible_party>
  <keyword>CAD</keyword>
  <keyword>ECP</keyword>
  <keyword>CFI</keyword>
  <keyword>CPI</keyword>
  <keyword>MPR</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Coronary Artery Disease</mesh_term>
    <mesh_term>Myocardial Ischemia</mesh_term>
    <mesh_term>Coronary Disease</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

